Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics.
Introduction
Cronos (CRON) reported its 2019 Q1 results and investors dumped the stock sending its shares down 7.1% for the week. Before Altria made its investments into Cronos, we had told our readers that Cronos is one of the weaker large-cap players in Canada. As Cronos reported disappointing results again last week, we think investors should embrace for a period of slow growth. However, potential M&A catalysts are made possible by